DocGo Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the DocGo Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, DocGo Inc. has logged 110 public disclosures. Market capitalisation: €64.3m. The latest transaction was reported on 14 May 2026 (Retenue fiscale). Among the most active insiders: Bienstock Lee. Every trade is free.
€348,650
12 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,915 of 29,063 companies
FCF yld 72%
Earn yld ·
EV/EBITDA ·
ROE -108%
Gross mgn 31%
Net mgn -57%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
All Executives110 Thresholds0 Prospectus0 Other0
Declarations 110 total
● Chief Executive Officer · Executives · 12 May 2026
15,644 shares @ US$0.59 0.014% mcap 50.0% of flow Common Stock SEC:0001920525-26-000004:0
● Chief Executive Officer · Executives · 30 Mar 2026
18,811 shares @ US$0.57 0.017% mcap 1.4% of flow Common Stock SEC:0001920525-26-000002:0
◆ Chief Executive Officer · Executives · 12 Dec 2025
1,113,495 shares 0Common Stock SEC:0001920525-25-000004:0
◆ Chief Compliance Officer · Executives · 12 Dec 2025
321,055 shares 0Common Stock SEC:0001917263-25-000004:0
◆ Director · Executives · 12 Dec 2025
150,000 shares 0Common Stock SEC:0001892208-25-000003:0
◆ Director · Executives · 12 Dec 2025
150,000 shares 0Common Stock SEC:0001825203-25-000004:0
◆ CFO and Treasurer · Executives · 12 Dec 2025
429,405 shares 0Common Stock SEC:0001439758-25-000004:0
◆ General Counsel and Secretary · Executives · 12 Dec 2025
100,000 shares 0Common Stock SEC:0001331867-25-000004:0
◆ Director · Executives · 12 Dec 2025
150,000 shares 0Common Stock SEC:0001324293-25-000004:0
◆ Director · Executives · 12 Dec 2025
150,000 shares 0Common Stock SEC:0001258177-25-000004:0
◆ Director · Executives · 10 Sept 2025
100,000 shares 0Common Stock SEC:0001213900-25-086890:0
● Chief Compliance Officer · Executives · 2 Jul 2025
5,813 shares @ US$1.52 4.0% of flow Common Stock SEC:0001822359-25-000070:0
● CFO and Treasurer · Executives · 2 Jul 2025
11,332 shares @ US$1.52 7.3% of flow Common Stock SEC:0001822359-25-000069:0
● Chief Executive Officer · Executives · 2 Jul 2025
18,597 shares @ US$1.52 3.5% of flow Common Stock SEC:0001822359-25-000068:0
▲ Director · Executives · 23 May 2025
10,000 shares @ US$1.33 12.4% of flow Common Stock SEC:0001822359-25-000056:0
Canonical exit: 21 Aug 2025 (T+90) ● Chief Executive Officer · Executives · 13 May 2025
15,565 shares @ US$1.44 3.0% of flow Common Stock SEC:0001822359-25-000053:0
▲ Director · Executives · 15 May 2025
15,000 shares @ US$1.43 20.1% of flow Common Stock SEC:0001822359-25-000054:0
Canonical exit: 13 Aug 2025 (T+90) ▲ Director · Executives · 14 May 2025
15,000 shares @ US$1.49 100.0% of flow Common Stock SEC:0001822359-25-000050:0
Canonical exit: 12 Aug 2025 (T+90) ▲ CFO and Treasurer · Executives · 14 May 2025
15,000 shares @ US$1.47 10.6% of flow Common Stock SEC:0001822359-25-000048:0
Canonical exit: 12 Aug 2025 (T+90) ▲ Chief Executive Officer · Executives · 14 May 2025
15,000 shares @ US$1.54 3.1% of flow Common Stock SEC:0001822359-25-000047:0
Canonical exit: 12 Aug 2025 (T+90) ▲ Chief Compliance Officer · Executives · 14 May 2025
10,000 shares @ US$1.44 7.1% of flow Common Stock SEC:0001822359-25-000049:0
Canonical exit: 12 Aug 2025 (T+90) ● CFO and Treasurer · Executives · 2 Apr 2025
8,004 shares @ US$2.68 10.6% of flow Common Stock SEC:0001822359-25-000031:0
● Chief Compliance Officer · Executives · 2 Apr 2025
5,614 shares @ US$2.68 7.6% of flow Common Stock SEC:0001822359-25-000032:0
● Chief Executive Officer · Executives · 31 Mar 2025
18,742 shares @ US$2.64 6.8% of flow Common Stock SEC:0001822359-25-000030:0
◆ Chief Compliance Officer · Executives · 7 Mar 2025
77,520 shares 0Common Stock SEC:0001822359-25-000026:0
25 of 110 declarations
Load more (85 remaining) 关于 DocGo Inc. DocGo Inc.(股票代码:DCGO)是一家在美国纳斯达克上市的美国医疗保健服务公司。该公司成立于2015年,原名Ambulnz,其创立理念很简单:当临床护理、运输物流和专有技术结合到一个运营平台时,医疗保健服务可以更高效。DocGo 总部位于纽约,这使其置身于一个竞争激烈的美国医疗保健市场,在这个市场中,规模、合同纪律和运营执行与临床能力同样重要。
公司的业务围绕两个核心支柱组织:移动健康服务和运输服务。移动健康包括上门和现场临床评估、诊断、分诊、治疗、药物管理以及其他将服务更贴近患者的护理交付计划。运输服务涵盖紧急响应能力以及非紧急医疗运输,包括救护车和轮椅运输。实际上,DocGo 将自己定位为远程医疗和实体护理交付之间的桥梁,利用技术调度团队、管理患者工作流程并协调合作伙伴之间的服务。
从竞争角度来看,DocGo 运营于移动护理、虚拟护理和医疗运输的交汇点。这种定位之所以重要,是因为美国医疗保健系统持续面临医院人满为患、人员短缺、成本控制以及将护理转移到成本较低环境的需求等压力。DocGo 的价值主张在于,它能够为医疗系统、支付方和公共部门客户快速建立合同服务并大规模运营。公司的业务范围主要在美国,但在英国也有业务,这使其具有适度的国际维度。
近期发展主要集中在扩展公司的护理交付平台和拓宽其服务组合。2025年10月,DocGo 收购了虚拟护理平台SteadyMD,以将远程医疗能力扩展到所有50个州。公司还在2025年末和2026年初宣布了新的计划和合作伙伴关系,包括长期护理服务、护理差距弥合计划以及额外的移动健康服务。管理层评论强调了核心运营量的增长以及从疫情相关工作向更持久、经常性医疗合同的持续转型。对于股票投资者而言,DocGo 仍然是一个以增长为导向的医疗保健平台,采用轻资产、技术驱动的模式,但其业绩仍取决于合同中标、报销动态和严格的利润执行。